CMS-Deemed Accreditation
DMEPOS Certification

Board of Certification/Accreditation

CMS-Deemed Accreditation
DMEPOS Certification

Policies and Procedures

Accreditation

The Board of Certification/Accreditation (BOC) developed Fraud, Waste, and Abuse (FWA) policies and procedures to help guide business owners, their employees, and the general public through the process of reporting adverse situations they may have encountered while utilizing the services of a durable medical equipment, prosthetics, orthotics and supplies (DMEPOS) provider.

The BOC Fraud, Waste, and Abuse (FWA) Case Procedures establishes the rules and procedures governing the investigation and resolution of alleged violations of the BOC Accreditation Standards, including the resulting disciplinary measures BOC may apply to businesses found to have violated these standards.

Use the BOC Fraud, Waste, and Abuse (FWA) Charge Statement to submit a FWA complaint against a BOC-accredited business or a business currently in the accreditation process. You must include a detailed description of factual allegations that support the charges against the business.

These policies and procedures are revisited regularly and may be amended in response to substantial real-world experience provided by BOC-accredited businesses.

If a supplier receives three or more complaints in one month, BOC reserves the right to conduct an on-site visit to investigate the complaints and the supplier will be invoiced for a resurvey fee. If the fee is not paid within 30 days, the supplier will be in jeopardy of accreditation revocation.

Have Questions? We Have Answers!

December 18, 2025

Statement from Board of Certification/Accreditation (BOC) Regarding Facility Accreditation

Note: All BOC certification programs remain relevant and valid for the thousands of providers holding BOC credentials.

The Board of Certification/Accreditation (BOC) confirms that the Centers for Medicare and Medicaid Services (CMS) notified BOC of its decision to immediately withdraw BOC’s status as a ‘deemed’ accrediting organization (AO) effective December 2, 2025.

BOC has sought guidance from CMS on how CMS plans to operationalize this abrupt change for BOC's customers. CMS advised that all inquiries regarding impact on supplier Medicare enrollment should be directed to the following email inbox: dmeaccreditation@cms.hhs.gov.

Those who value accreditation and are committed to DMEPOS product access and patient safety understand that accreditation operations cannot be abruptly halted without resulting in a negative impact on DMEPOS suppliers and the patients/beneficiaries they serve.

In response to CMS' abrupt termination, BOC has filed Board of Certification/Accreditation International, Inc. v. Robert F. Kennedy, Jr. et al, Case No. 1:25-cv-04150-MJM, in the United States District Court of Maryland.

Since December 2, our focus has been on the DMEPOS customers most immediately impacted: new and reaccrediting facilities in the midst of completing the final requirements to confirm compliance and receive accreditation. Some of these customers were surveyed weeks prior to CMS issuing the December 2 notice of withdrawal.

BOC is dismayed by the actions of CMS, particularly with its refusal to have verbal conversations with BOC before withdrawing BOC's deemed status.

Download this statement